These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9458532)

  • 21. Management of venous access devices by Advanced Practice Nursing teams: more research needed.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):473-4. PubMed ID: 23039923
    [No Abstract]   [Full Text] [Related]  

  • 22. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term central venous lines and their complications].
    Teichgräber UK; Gebauer B; Benter T; Wagner J
    Rofo; 2004 Jul; 176(7):944-52. PubMed ID: 15237335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rotation of an implanted port catheter system by 180 degrees--a complication that should be recognized].
    Langen HJ; Biewener C; Selbach KD
    Rofo; 2007 Jul; 179(7):745-6. PubMed ID: 17492545
    [No Abstract]   [Full Text] [Related]  

  • 25. [Central venous catheters in children with cancer. Risk of complications. One centre experience].
    Perek D; Kowalewska E; Czajnska A; Polnik D; Drogosiewicz M; Stefanowicz M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):757-65. PubMed ID: 17317906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safe removal of central venous catheters.
    Ingram P; Sinclair L; Edwards T
    Nurs Stand; 2006 Aug 16-22; 20(49):42-6. PubMed ID: 16939143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter-associated thrombosis: thromboprophylaxis or not?
    Levine M; Kakkar AK
    J Clin Oncol; 2005 Jun; 23(18):4006-8. PubMed ID: 15767646
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of central venous catheters for prolonged venous access in cancer chemotherapy.
    Rajoor BG; Charak BS; Banavali SD; Iyer RS; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1990 May; 38(5):340-2. PubMed ID: 2387816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fate of 100 prolonged venous access devices.
    Hayward SR; Ledgerwood AM; Lucas CE
    Am Surg; 1990 Sep; 56(9):515-9. PubMed ID: 2393188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing complications of central venous access devices.
    Masoorli S
    Nursing; 1997 Aug; 27(8):59-63; quiz 64. PubMed ID: 9295639
    [No Abstract]   [Full Text] [Related]  

  • 31. [Venous thrombosis on central catheters in oncology].
    Devie-Hubert I; Carlier M; Pozzo Di Borgo C
    Rev Med Interne; 1996; 17(10):821-5. PubMed ID: 8976975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internal thoracic vein cannulation as a complication of central venous catheter insertion.
    Lee AC; Patel JV; Picton SV; Squire R
    Med Pediatr Oncol; 2003 Mar; 40(3):195-6. PubMed ID: 12518352
    [No Abstract]   [Full Text] [Related]  

  • 33. Reductions in tissue plasminogen activator and thrombomodulin in blood draining veins damaged by venous access devices.
    Horne MK; Merryman PK; Mayo DJ; Gralnick HR; Chang RC; Alexander HR
    Thromb Res; 1995 Aug; 79(4):369-76. PubMed ID: 7482440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging and management of complications of central venous catheters.
    Nayeemuddin M; Pherwani AD; Asquith JR
    Clin Radiol; 2013 May; 68(5):529-44. PubMed ID: 23415017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the introduction of the Groshong central venous catheter into the oncology/haematology department of a district general hospital.
    Todd J
    Eur J Cancer Care (Engl); 1997 Sep; 6(3):215-21. PubMed ID: 9335673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accessing implanted ports: still a source of controversy.
    Eisenberg S
    Clin J Oncol Nurs; 2011 Jun; 15(3):324-6. PubMed ID: 21624868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign.
    Faraj W; Zaghal A; El-Beyrouthy O; Kutoubi A
    Ann Vasc Surg; 2010 Jul; 24(5):692.e11-5. PubMed ID: 20413259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on implantable chambers].
    Nahum S
    Soins Gerontol; 2006; (61):17-20. PubMed ID: 17063848
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of the patient receiving infusional cancer chemotherapy: nursing role in recognition and management of catheter-related complications. The Cancer Center of Boston.
    Moore C; Strong D; Childress J; Fougere B; Gotthardt S
    J Infus Chemother; 1996; 6(4):171-80. PubMed ID: 9229312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.